Related Experiment Video
Updated: Sep 19, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Curcumin in Type 2 Diabetes Mellitus: A Natural Approach to Modulating Metabolic Dysfunction
Rufaida Wasim1, Sumaiya Azmi2, Mohammad Owais1
1Faculty of Pharmacy, Integral University, Lucknow (UP) India.
Curcumin, a compound from turmeric, shows promise in managing type 2 diabetes mellitus (T2DM). Its anti-inflammatory and antioxidant properties help control blood sugar and improve insulin resistance, suggesting potential as a natural T2DM treatment.
Area of Science:
- Pharmacology
- Metabolic Diseases
- Natural Products
Background:
- Type 2 diabetes mellitus (T2DM) is a growing global health issue.
- Bioactive compounds from herbal medicine offer therapeutic benefits for T2DM.
- Curcumin, from turmeric (Curcuma longa), is gaining attention for its health effects.
Purpose of the Study:
- To summarize the antidiabetic actions and mechanisms of curcumin.
- To review preclinical and clinical evidence supporting curcumin's role in T2DM prevention and management.
Main Methods:
- Review of in vitro and in vivo studies on curcumin's pharmacological effects.
- Analysis of preclinical research and clinical trials on curcumin's antidiabetic properties.
Main Results:
- Curcumin exhibits antioxidant, anti-inflammatory, hypoglycemic, and insulin-sensitizing effects.
- Animal models show curcumin improves -cell function and reduces insulin resistance.
- Evidence suggests curcumin's efficacy through multiple pathways, including anti-inflammatory and antioxidant actions.
Conclusions:
- Curcumin demonstrates significant potential for the prevention and management of T2DM.
- Its multifaceted properties, including anti-inflammatory, antioxidant, antihyperglycemic, and antihyperlipidemic effects, contribute to its therapeutic success.
- Curcumin represents a promising natural therapeutic option for T2DM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

